Related Experiment Video
Updated: Jun 7, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
112
A Feature-Fusion Technique-Based Alzheimer's Disease Classification Using Magnetic Resonance Imaging
Abdul Rahaman Wahab Sait1, Ramprasad Nagaraj2
1Department of Archives and Communication, Center of Documentation and Administrative Communication, King Faisal University, P.O. Box 400, Hofuf 31982, Al-Ahsa, Saudi Arabia.
Diagnostics (Basel, Switzerland)
|November 9, 2024
Summary
This study introduces an interpretable and efficient deep learning model for Alzheimer's disease (AD) classification using MRI images. The novel approach achieves high accuracy, offering a valuable tool for early AD detection in resource-limited settings.
Area of Science:
- Artificial Intelligence
- Medical Imaging
- Neuroscience
Background:
- Early Alzheimer's disease (AD) detection is crucial for effective management.
- Deep learning (DL) models like CNNs and ViTs show promise for AD diagnosis but often lack interpretability and require significant computational resources.
- Hybrid Vision Transformers (ViTs) offer improved feature visualization and interpretability with reduced computational demands.
Purpose of the Study:
- To present an innovative, resource-efficient model for classifying Alzheimer's disease (AD) using MRI images.
- To address the limitations of existing deep learning models in terms of interpretability and computational cost.
Main Methods:
- Modified existing Vision Transformers (ViTs) to enhance Alzheimer's disease (AD) feature extraction.
- Employed a CatBoost-based classifier for multi-class classification of extracted features.
- Validated the model's generalization capabilities on the OASIS dataset.
Main Results:
- The proposed model achieved a high classification accuracy of 98.8% on the OASIS dataset.
- The model demonstrated a minimal loss value of 0.12, indicating strong performance.
- The approach proved effective in classifying Alzheimer's disease (AD) with high precision.
Conclusions:
- The developed model presents an interpretable and computationally efficient solution for Alzheimer's disease (AD) classification in healthcare settings.
- Future research should incorporate genetic and clinical data to further enhance model robustness and applicability.
- This work highlights the potential of hybrid ViTs in medical diagnostics.
Keywords:
CatBoostdeep learningfeature extractionfeature fusionmagnetic resonance imagingvision transformerMore Related Videos
Related Concept Videos
Magnetic Resonance Imaging
4.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
4.9K
Brain Imaging
211
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
211
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448

